Pieris Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Pieris Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma (NCT05190445) | Pieris Pharmaceuticals, Inc. | 2021-11-01 |
| PRS-343 in HER2-Positive Solid Tumors (NCT03330561) | Pieris Pharmaceuticals, Inc. | 2017-09-13 |
Track Pieris Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.